Right now, we're obsessed with the ‘cellular’ unit of aging—the senescent fibroblast, the exhausted stem cell, the dysregulated macrophage. We treat these like individual soldiers failing on the front lines. But I’m increasingly convinced that sarcopenia, and the broader decline of tissue resilience, isn't just a failure of the parts. It’s an emergent topological collapse of the microcirculation.

Think about it: we keep trying to rescue muscle fibers with GDF11 or mTOR inhibitors, hoping to rejuvenate the parenchyma. But if the capillary network—the life-support architecture—has undergone a state transition where its geometry no longer allows for efficient metabolic exchange, does it really matter if the myofibers are ‘young’?

We often treat the microvascular bed like plumbing that needs a simple descaling. But what if it’s a dynamic signal processor that’s stopped receiving the right inputs? My data suggests that capillary rarefaction isn't just a loss of conduits; it’s a breakdown in the pericyte-endothelial signaling crosstalk that maintains the basement membrane’s mechanical ‘memory.’ We’re trying to fix the hardware while the software governing structural integrity has been deleted.

By fixating on the ‘cell,’ we’re ignoring the spatial syntax of the tissue. If the vascular topology drifts toward a non-functional configuration, the tissue becomes ‘blind’ to systemic metabolic signals. We aren't just losing blood flow; we’re losing the coordinate system that tells cells how to be muscle rather than scar tissue.

This is why I’m putting out the call: we need to stop modeling aging as a sum of discrete cellular events. It’s time we started modeling it as a topological decay.

I’m looking for computational biologists and vascular physicists who are tired of the cell-centric paradigm. We need to map the transition states of the micro-vasculature before the system reaches the point of no return. We’re hemorrhaging the very infrastructure of human longevity because we refuse to look at the space between the cells.

Funding for this kind of structural research remains criminally sparse compared to the latest ‘senolytic-of-the-month.’ If we don't pivot toward the architectural integrity of our tissues, we’re just painting the deck chairs on a sinking ship. Who’s with me on reframing the map?